The Biggest Bottlenecks Holding Back Cell and Gene Therapy Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges August 24, 2026 10 min The Medicine Maker Share Takeaways Insight Report Clinical Scorecard Quiz Poll Topic Commentary